Serum Institute seeks DCGI's approval for Covishield as booster dose

In an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at Serum Institute of India (SII) cited that the UK's Medicines and Healthcare products Regulatory Agency has already approved the booster dose of AstraZeneca ChAdOx1 nCoV-19 vaccine, they said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3I3d1D8
via IFTTT